Tofflon Science and Technology Group Co., Ltd. (300171.SZ)

CNY 14.33

(-0.14%)

Market Cap (In CNY)

10.9 Billion

Revenue (In CNY)

5.64 Billion

Net Income (In CNY)

600.23 Million

Avg. Volume

4.37 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.6-18.08
PE
-
EPS
-
Beta Value
0.598
ISIN
CNE100000ZP0
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Dehua Lu
Employee Count
-
Website
https://www.tofflon.com
Ipo Date
2011-02-01
Details
Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It offers injectables, such as auto solution preparation systems, aseptic filling lines for ampoule, vials, syringes and powders, freeze dryer and auto loading systems, barrier systems, and plastic packaging machines. The company also provides active pharmaceutical ingredients; and visual inspection, leak detection, and combination systems, as well as focuses on providing bio-process equipment and integrated systems, including medium preparation, cell/microbial cultivation, harvesting, DF/UF, purification, buffer preparation, and finished filling systems. In addition, it offers lyophilization injectable lab services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. The company was founded in 1993 and is headquartered in Shanghai, China.